Bael

Bael (Aegle marmelos): A Comprehensive Reference

1. Identity, Botanical Classification, and Common Forms

1.1 Botanical and Scientific Identity

Aegle marmelos (L.) Corrêa, commonly known as the bael fruit tree, is a member of the Rutaceae family. Also known as "golden apple," it belongs to the monotypic genus Aegle and is a small to medium-sized tree reaching up to 13 metres tall with drooping branches. It is a slow-growing, hardy subtropical tree and the only plant in the genus Aegle. Trees grow in forests up to a height of 12 to 15 metres, even in tough conditions, and bear spiny branches with alternate leaves composed of three to five oval and shallowly toothed leaflets.

1.2 Vernacular and Synonymous Names

Known as Bilva or Bael, the plant has a rich history in traditional Indian medicine. Its leaves, fruits, and roots are used in Ayurveda and Siddha for their therapeutic properties, including anti-inflammatory, anti-diabetic, and antioxidant effects. It is a member of the Rutaceae family and is utilised in various formulations. Synonyms in English include Bael, Bengal quince, Wood apple, and Stone apple. In Sanskrit it is called Bilva, and in Tamil Vilvam.

1.3 Geographic Distribution and Natural Source

Aegle marmelos or bael has a long history of use in traditional medicine across Southeast Asia, with roots in the ancient Indian traditional medicinal system of Ayurveda. It is a medium-sized deciduous plant endemic to India and Southeast Asia, reaching a height of roughly 18 metres. It is found all over India, including the Himalayas and the South Indian plateau. The plant bears globose fruits with a smooth, rough, aromatic shell and a diameter of 5–15 cm. The fruit bears various seeds enclosed in a thick aromatic pulp coated with dense fibrous hair.

1.4 Plant Parts Used and Common Preparations

Bael has therapeutic characteristics in all of its parts, notably the fruits, leaves, roots, stem, and bark. Many different kinds of tablets, pastes, and powders are produced from the plant. Bael is a key component in the creation of dashmula (meaning "ten roots," which is used to treat colitis, dysentery, diarrhea, flatulence, and fever), and chyawanprash.

Bael fruits are of dietary use, and the fruit pulp is used to prepare delicacies like murabba, puddings, and juice. The plant is indigenous to India and has been used by inhabitants of the Indian subcontinent for over 5,000 years. Bael fruit can be used widely as powder, wine, preserve, jam, and juice. Unripe slices are sometimes roasted or boiled, dried under shade, and powdered — especially in Eastern Indian traditions.

2. Traditional and Historical Use

2.1 Ayurveda

Aegle marmelos or bael has been known from Neolithic times in India with mythological significance. Indigenous to India, it has been used by inhabitants of the Indian subcontinent for over 5,000 years. The leaves, bark, roots, fruits, and seeds are used extensively in the Indian traditional system of medicine — Ayurveda — and in various folk medicines to treat myriad ailments.

In Ayurveda, the plant is used in Panchang form (all five plant parts) to treat diarrhea, dysentery, and ulcer. In folklore, the plant parts are also used to treat diabetes, skin diseases, and typhoid, as well as for wound healing. In Ayurveda, the plant is used to cure indigestion, intermittent fever, typhoid, cholera, heart palpitation, and heart, stomach, and intestinal disorders, owing to its carminative and digestive properties.

The roots of the plant are commonly used as an important ingredient in the Ayurvedic drug named Dashamoola, which is used to cure dysentery, colitis, diarrhea, flatulence, loss of appetite, and fever since ancient times. In Ayurveda, the plant is known to balance vata, pitta, and kapha dosha.

2.2 Siddha, Unani, and Folk Medicine

Bael leaves (Aegle marmelos) hold a significant place in Ayurveda, traditional Chinese medicine, and other indigenous healing systems. The books of medicinal systems like Ayurveda, Siddha, and Unani are rich with herbal medicine scriptures. The unripe fruit and leaves are key components of treatments in Ayurveda for conditions like persistent diarrhea, dysentery, and diabetes. Bael leaf juice is taken on an empty stomach early in the morning by diabetic patients, and is said to reduce sugar levels in about a month.

2.3 Spiritual and Cultural Significance

Bael (Aegle marmelos Correa) is considered a sacred tree by Hindus and is offered to Lord Shiva while worshipping. In Jainism, Aegle marmelos, known as Malura, is linked to the worship of Shiva. The text emphasizes the use of its leaves in Shiva rituals, providing a specific context for understanding the tree's significance within this religious tradition. The leaves of the Bael tree are used not only for their medicinal properties but also as offerings to Lord Shiva and other deities.

2.4 Traditional Preparations by Plant Part

Leaves, fruits, stem, and roots of A. marmelos have been used in ethnomedicine to exploit its medicinal properties including astringent, antidiarrheal, antidysenteric, demulcent, antipyretic, and anti-inflammatory activities. The unripe fruit is associated with more medicinal value compared to the ripe fruit. Bael has been credited with treatment capability to cure diarrhea, chronic dysentery, constipation, gonorrhea, catarrh, diabetes, deafness, inflammations, ulcerated intestinal mucosa, intermittent fever, melancholia, and heart palpitation.

3. Key Phytochemical Constituents

3.1 Overview of Chemical Classes

Aegle marmelos has undergone extensive research on various components, leading to the isolation of many types of compounds, including alkaloids, coumarins, terpenoids, fatty acids, amino acids, tannins, flavonoids, and saponins. Over 100 bioactive ingredients have been isolated from the plant.

Aegle marmelos has been widely utilized in traditional medicinal systems. It has been reported to contain numerous phytochemical compounds such as polyphenol/phenolic compounds, carotenoids, alkaloids, pectin, flavonoids, tannins, coumarins, and terpenoids.

3.2 Coumarins (Dominant Class)

The most frequently reported bioactive classes are coumarins (marmelosin, imperatorin, and psoralen), alkaloids (aegeline), flavonoids (rutin, quercetin), and phenolic acids (gallic acid and ferulic acid). These are repeatedly linked to key pharmacological activities such as antidiabetic, antioxidant, anticancer, and wound-healing effects. Coumarins and flavonoids, in particular, emerge as dominant contributors to the therapeutic potential of Bael, consistent with their wide occurrence in Rutaceae plants.

Aegle marmelos fruit has been reported to contain phytoconstituents such as marmelosin, marmelide, psoralen, alloimperatorin, rutaretin, scopoletin, aegeline, umbelliferone, marmelin, fagarine, anhydromarmelin, limonene, α-phellandrene, betulinic acid, marmesin, luvangentin, and auroptene. The amount of marmelosin in bael fruit varies from 415.75 to 737 μg/g, and the total phenolic content varies from 10.6 mg GAE/g to 25.14 mg GAE/g, depending on drying conditions. Significant levels of carotenoids like β-carotene (51.67–153.43 μg/100 g) and coumarins such as imperatorin and marmelosin have also been reported.

3.3 Alkaloids

A. marmelos is reported to contain alkaloids including aegeline, fragrine, and aegelenine, as well as coumarins (marmin, marmelide, psoralen, imperatorin) and terpenoids (cineol, caryophyllene). Aegeline (0.15–0.25 mg/g) and skimmianine are two alkaloids that enhance its pharmacological activity.

3.4 Nutritional Composition

Vitamin C levels in unripe bael fruit are relatively high (620 mg/100 g). Additionally, vitamin C (8–60 mg), riboflavin (1.19 mg), vitamin A (55 mg), thiamine (0.13 mg), potassium (600 mg), calcium (85 mg), niacin (1.1 mg), and phosphorus (50 mg) are all known to be present in bael fruit.

4. Mechanisms of Action

4.1 Anti-inflammatory Pathways

Various activities of Bael may be attributed to its ability to passivate different free radicals and suppress nuclear factor-κB (NF-κB), tumor necrosis factor alpha, cyclooxygenase I and II, interleukins, AKT, and vascular endothelial growth factor. Marmelosin, a compound isolated from bael fruit, has anti-inflammatory properties, lowering nitric oxide and tumor necrosis factor, a pro-inflammatory cytokine.

4.2 Antidiabetic Mechanisms

Anti-diabetic activity has been attributed to compounds such as aegeline and citral, which inhibit DPP-4 through interactions with Glu205 and Glu206 residues, thus supporting glucose homeostasis. Quercetin and coumarins also display DPP-IV inhibition, reinforcing the anti-diabetic effect.

4.3 Antimicrobial Mechanisms

Imperatorin shows antibacterial action against S. dysenteriae by targeting Cu-Zn superoxide dismutase, leading to oxidative stress-induced cell death. Bael leaf extracts demonstrated broad-spectrum antimicrobial activity in vitro against bacterial species including Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli, and Salmonella typhi, and fungi including Candida albicans, Candida tropicalis, and Aspergillus flavus, with minimum inhibitory concentrations (MIC) of 1.25 to 10 mg/mL and minimum microbicidal concentrations (MMC) of 2.5 to 20 mg/mL.

4.4 Antioxidant Mechanisms

Phytochemical compounds in bael act as metal chelators, reducing agents, singlet oxygen quenchers, or hydrogen donors, owing to their redox properties, which account for their antioxidant capacity. The antioxidant potential of Aegle marmelos is attributed to its high content of phenolic compounds, which help in scavenging free radicals and reducing oxidative stress.

4.5 Neurological Mechanisms

The coumarin molecule marmelosin inhibits acetylcholinesterase (AChE), a crucial mechanism for enhancing cognitive function and managing Alzheimer's disease. Marmelosin improves neurotransmission and lessens Alzheimer's disease symptoms by raising acetylcholine (ACh) levels through AChE inhibition. Aegeline, a compound isolated from A. marmelos, has shown protective effects against Parkinson's disease by mimicking the yeast soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) protein Sec22p to suppress α-synuclein-induced toxicity.

4.6 Anticancer Mechanisms

Previous studies have shown that bael fruit extract, containing marmesin and marmelosin, inhibits HSULF-2 (human heparan sulfatase-2) activity and kills breast tumor cells. Docking studies revealed marmesin and marmelosin as potential HSULF-2 inhibitors with binding scores of −8.5 and −7.7 Kcal/mol respectively.

5. Scientific Evidence by Area of Use

5.1 Gastrointestinal Disorders (Diarrhea and Dysentery)

Bael fruits are used in the treatment of chronic diarrhea, dysentery, and peptic ulcers, as a laxative, and to recuperate from respiratory affections in various folk medicines.

Preclinical evidence: In preclinical work, the decoction of dried unripe fruit pulp of A. marmelos was evaluated for its effect on various parameters of diarrhoeal pathogenicity, including adherence to and invasion of intestinal epithelium and production and action of enterotoxins. According to published reports, A. marmelos is effective in chronic cases of diarrhoea due to the presence of large quantities of mucilage, which acts as a demulcent. Additionally, A. marmelos has been shown to be effective in experimental models of irritable bowel syndrome and physiological diarrhoea.

Evidence strength: Extensive studies show that A. marmelos has antidiarrhoeal, antimicrobial, antiviral, anticancer, chemopreventive, antipyretic, ulcer-healing, antigenotoxic, diuretic, antifertility, and anti-inflammatory properties. However, the large majority of this evidence is from preclinical (animal and in vitro) models; high-quality randomized clinical trials specifically for acute or infectious diarrhea are lacking.

5.2 Diabetes and Blood Glucose Regulation

Human/clinical evidence: Yaheya and Ismail (2009) administered 5 g bael leaf powder once daily to twenty type-2 diabetic patients with postprandial blood glucose of 201 ± 6 mg/dL; after 16 weeks, their postprandial blood glucose effectively reduced to 159 ± 5 mg/dL.

A further study reported that administration of 4 g bael leaf extract daily (2 g twice a day) along with a sulfonylurea in non-insulin dependent diabetes mellitus (NIDDM) patients for eight weeks significantly decreased blood glucose and urinary glucose levels.

In an experimental trial in Gujarat, supplementation with Aegle marmelos leaf juice (20 g/100 mL) in confirmed type-2 diabetes mellitus patients for 60 days showed improvements in biochemical markers.

Proposed mechanisms: Bael has demonstrated significant efficacy in regulating blood glucose levels, enhancing insulin sensitivity, and protecting pancreatic beta cells.

Evidence strength: The clinical studies are small and of limited methodological quality. Although A. marmelos has been historically revered in Ayurvedic and Siddha systems for its wide therapeutic applications, its integration into modern clinical practice remains limited by insufficient translational data. The antidiabetic effects require confirmation through larger, well-designed randomized controlled trials.

5.3 Hepatoprotection

Preclinical evidence: Treatment with A. marmelos extract reduced the severity of carbon tetrachloride (CCl₄)-induced liver toxicity in a dose-dependent fashion, and results of the A. marmelos extract 50 mg/kg group were comparable to the silymarin group. The low dose of A. marmelos extract (25 mg/kg) alone did not significantly reverse hepatotoxicity, but in combination with piperine showed significant reversal. In conclusion, A. marmelos exerts hepatoprotective activity through its antioxidant and anti-inflammatory properties.

In a dietary inclusion experiment, administration of the fruit part of Aegle marmelos to Wistar rats showed a significant reduction in elevated liver enzymes including ALT, AST, ALP, ACP, and bilirubin in cisplatin-induced hepatotoxicity models.

Evidence strength: All hepatoprotective evidence is from animal models. No clinical human trials on hepatoprotection have been published. The potency of Aegle marmelos suggests potential for the development of safe and inexpensive hepatoprotective drugs from natural sources, but further work is needed.

5.4 Anticancer Activity

In vitro evidence: MTT assays on the human breast cancer cell line MCF-7 at various concentrations confirmed in vitro anticancer activity. Extract of Aegle marmelos acts by showing anti-proliferative activity on breast cancer cells, inhibiting cell proliferation. Constituents such as lupeol (a triterpenoid) and marmelin (1-hydroxy-5,7-dimethyl-2-naphthalene-carboxaldehyde) are responsible for exhibiting efficacy against breast cancer treatment.

Evidence strength: Some research studies (animal and laboratory) suggest this plant might have anti-cancer, anti-inflammatory, and antioxidant properties. All anticancer evidence currently derives from in vitro cell-line and animal studies. No human clinical trial data exist for cancer treatment or chemoprevention using bael.

5.5 Neurological Disorders

Preclinical evidence: Existing research on A. marmelos primarily focuses on preclinical models, where its extracts have demonstrated acetylcholinesterase (AChE) inhibitory activity, suggesting potential benefits for Alzheimer's disease. Effects and mechanisms of A. marmelos extract in addressing Alzheimer's disease, anxiety, depression, epilepsy, and Parkinson's disease have been explored.

Evidence strength: Although A. marmelos has long been used to treat a variety of illnesses including neurological problems, thorough research confirming its effectiveness and clarifying its processes in treating particular neurological issues is lacking. The limited preclinical studies on A. marmelos' efficacy in treating neurological disorders emphasize the need for more clinical trials to validate its potency and safety.

5.6 Antimicrobial Activity

In vitro evidence: Bael demonstrates antibacterial, antifungal, antiviral, antimalarial, and antiparasitic activities. The ethanolic extract of Aegle marmelos showed higher antibacterial activity compared to the aqueous extract; T. chebula and A. marmelos had the strongest antibacterial activity in a comparative study of five medicinal plants.

Evidence strength: Antimicrobial activity is well-documented in in vitro studies across multiple pathogen types, but this has not been translated into clinical trials validating efficacy in treating human infections.

5.7 Cardioprotection and Lipid Modulation

Aegeline, auroptene, umbelliferone, psoralene, marmin, imperatorin, xylorhamnoarabinogalactan I pectic polysaccharide, and skimmianine are synthesized by different parts of bael, and they have shown antibacterial, anti-inflammatory, analgesic, anti-allergic, anthelmintic, antidiabetic, anticancer, cardioprotective, and neuroprotective activities in various experimental models.

Bael has enormous traditional uses in the treatment of chronic diarrhea, dysentery, peptic ulcers, and as a laxative. In a preclinical study, normal rat groups were administered diets containing bael leaf extract at 125 mg and 250 mg, respectively, for 60 consecutive days, assessing antihypercholesterolaemic and antilipidaemic effects.

5.8 Antifertility Activity

Preclinical evidence: A study was undertaken to evaluate the effect of Aegle marmelos bark extract on fertility in rats, as the extract is a rich source of marmin and fagarine known for reducing male fertility. Three different concentrations of methanolic bark extracts (200, 400, and 600 mg/kg body weight) were evaluated for male antifertility activity on albino Wistar rats, administered orally for 60 days. Sperm analysis results showed reduction in sperm density, motility, viability, and sperm acrosomal integrity without interfering with libido and vital organ body weight. Histopathological studies of testes revealed exfoliation of elongated spermatids, nuclear chromatin condensation, degeneration, and prominent spaces within the germinal epithelium, signifying testicular cytotoxicity. Time-dependent complete infertility was observed at all dose levels. Animals showed restoration of morphological and physiological parameters after 30 days of withdrawal from treatment.

Evidence strength: All antifertility evidence is from animal models only; no human reproductive studies have been conducted.

5.9 Radioprotection

Extensive experimental and clinical studies prove that Aegle marmelos possesses antidiarrhoeal, antimicrobial, antiviral, radioprotective, anticancer, chemopreventive, antipyretic, ulcer healing, antigenotoxic, diuretic, antifertility, and anti-inflammatory properties. The radioprotective evidence is predominantly preclinical (animal and cell-line based), involving protection against radiation-induced oxidative damage.

6. Body Systems and Health Areas Associated with Bael

• Gastrointestinal system: Antidiarrheal, antidysenteric, antiulcer, laxative (ripe fruit), antispasmodic, gastroprotective, and treatment of inflammatory bowel conditions.
• Endocrine/Metabolic system: Antidiabetic, antihyperlipidemic, and antiobesity effects.
• Immune and Antimicrobial: Antibacterial, antifungal, antiviral, and antiparasitic activities.
• Hepatic system: Hepatoprotective activity against chemical and drug-induced liver injury in animal models.
• Cardiovascular system: Cardioprotective and lipid-modulating effects in preclinical models.
• Neurological system: Preclinical evidence for effects on Alzheimer's disease, Parkinson's disease, anxiety, and depression.
• Oncology (experimental only): Anti-proliferative and cytotoxic effects in cell lines.
• Reproductive system: Antifertility effects documented in animal models.
• Integumentary system: Wound healing activity.
• Radioprotection: Protection against radiation-induced cellular damage in experimental models.

Bael extracts from various plant parts have demonstrated therapeutic effects in inflammation, cancer, diabetes, microbial infections, neurodegeneration, wound healing, and mood disorders.

7. Dosage Forms and Doses Reported in Studies

7.1 Leaf Powder (Human Studies)

Yaheya and Ismail (2009) administered 5 g bael leaf powder once daily to type-2 diabetic patients for 16 weeks. A separate study used 4 g bael leaf extract daily (2 g twice a day) along with a sulfonylurea drug in NIDDM patients for eight weeks.

7.2 Leaf Juice (Human Study)

An experimental trial in Gujarat administered bael leaf juice at 20 g/100 mL to confirmed type-2 diabetes mellitus patients for 60 days.

7.3 Animal Study Doses

In the carbon tetrachloride hepatotoxicity rat model, treatment with A. marmelos at 50 mg/kg significantly reduced the severity of toxicity in a dose-dependent fashion, with results comparable to the silymarin group. The low dose of 25 mg/kg alone did not significantly reverse hepatotoxicity, but did so in combination with piperine.

In the male antifertility rat study, methanolic bark extract of Aegle marmelos was administered orally at 200, 400, and 600 mg/kg body weight for 60 days.

In the antilipidaemic rat study, groups were fed bael leaf extract at 125 mg and 250 mg for 60 consecutive days.

7.4 Safety Margins from Animal Data

Animal studies indicate that A. marmelos leaf extracts do not induce toxicity across a range of doses (50, 70, 90, and 100 mg/kg body weight), giving a high margin of drug safety. Even a dose of 250 mg/kg did not show any adverse effect in animal models.

7.5 Traditional Ayurvedic Dosage Forms

Many different kinds of tablets, pastes, and powders are produced from the plant. Bael is a key component of dashmula and chyawanprash preparations. The pulp of the bael fruit is rich in bioactive substances such as carotenoids, phenolics, alkaloids, pectins, tannins, coumarins, flavonoids, and terpenoids. Methanol and water are the best solvents for extracting the metabolites of this plant, followed by ethanol.

8. Safety Considerations and Drug Interactions

8.1 The Aegeline-Linked Hepatotoxicity Episode (2012–2013)

Aegeline, also known as N-[2-hydroxy-2-(4-methoxyphenyl)ethyl]-3-phenyl-2-propenamide, is an ingredient that has been added to some dietary supplements, especially those marketed for weight loss and muscle building. It is naturally found in the Aegle marmelos (bael) tree, which is used in Ayurvedic medicine, and can also be synthesized in a laboratory.

Cases of severe hepatitis were reported among individuals consuming "OxyELITE Pro Super Thermogenic," some of which required emergency liver transplantation and a few resulted in death. Between 2012 and 2014, the FDA received 114 adverse event reports associated with OxyELITE Pro use; among these, 33 patients (60%) required hospitalization, and three underwent liver transplantation. In response to these reports and an FDA warning letter citing aegeline as an unapproved ingredient lacking safety data, the manufacturer initiated a nationwide recall of OxyELITE Pro products in November 2013.

The aegeline used in OxyELITE Pro implicated in liver injury, however, was a synthetic product produced in China and may have included contaminants, synthetic precursors, metabolic derivatives, or racemic forms of the chemical that are toxic or immunogenic.

Racemic synthetic aegeline studied in Wistar rats failed to show any hepatotoxic effects, while demonstrating similar anti-oxidative, anti-inflammatory, and hepatoprotective effects typically seen with A. marmelos extracts. In vitro, animal model, and epidemiological data demonstrate a lack of hepatotoxic effects with [pure] aegeline itself. Nonetheless, the safety of synthetic or isolated aegeline in humans remains unresolved pending dedicated clinical studies.

Aegeline is on the DoD (U.S. Department of Defense) Prohibited Dietary Supplement Ingredients list. In 2013, the FDA issued a warning letter about aegeline in two dietary supplement products, because it was not recognized as a legitimate ingredient for dietary supplements.

8.2 CYP Enzyme Inhibition and Drug–Drug Interaction Potential

A study evaluated the inhibitory potential of methanolic extract of A. marmelos fruit and its constituents — three furanocoumarins (marmelosin, marmesinin, and 8-hydroxypsoralen) and the alkaloid aegeline — towards major cytochrome P450 enzymes (CYP3A4, 2D6, 1A2, 2C9, and 2C19) using human liver microsomes and recombinant CYPs. The methanolic extract and marmelosin were found to be competitive and time-dependent inhibitors of CYP3A4. Reversible and non-competitive inhibition was observed for CYP1A2.

This was the first report of CYP3A4 and CYP1A2 inhibition by A. marmelos extract and one of its furanocoumarins, marmelosin. Because CYP3A4 and CYP1A2 are responsible for metabolizing a large proportion of pharmaceutical drugs, this in vitro finding carries theoretical relevance for herb–drug interactions, though the clinical significance of this inhibition at normal dietary or supplemental doses has not been established in human studies.

8.3 Antifertility Considerations

Studies suggest Aegle marmelos bark methanolic extract is a strong candidate for male contraception, via its ability to produce complete inhibition of pregnancy and rapid restoration of fertility after withdrawal from treatment. This antifertility activity, observed in animal models, implies that reproductive-age individuals should be aware of this potential effect until human data are available.

8.4 Photosensitization Potential

The plant contains psoralens (including psoralen itself and imperatorin), which are furanocoumarins well-established as photosensitizers in other plant sources. A. marmelos is reported to contain coumarins including marmin, marmelide, psoralen, and imperatorin. The photosensitizing risk from bael-derived psoralens at food or supplement doses has not been specifically quantified in clinical settings.

8.5 General Preclinical Safety Profile

This plant does indeed have pharmacological properties of interest; however, further extensive research is needed to establish a potential strategy that can balance the pharmacological and toxic effects of bael. The integration of Aegle marmelos into mainstream medicine faces challenges, including variability in its phytochemical composition, lack of standardized formulations, and insufficient clinical evidence.

9. Summary of Evidence Quality

Comprehensive syntheses of in vitro, in vivo, and clinical evidence confirm pharmacological potential for bael and its bioactive compounds including marmelosin, aegeline, imperatorin, gallic acid, and rutin. However, the overall picture of clinical evidence is uneven:

• Best-supported area: Antidiarrheal and gastrointestinal uses, supported by ethnobotanical validation and preclinical mechanistic studies, with limited human data.
• Moderate evidence: Antidiabetic effects, with several small human studies showing positive results but lacking rigorous RCT methodology and standardization.
• Preliminary/in vitro only: Anticancer, neuroprotective, cardioprotective, and radioprotective activities — these are based on cell-line and animal experiments only.
• Animal-only: Antifertility, hepatoprotective, and antihyperlipidemic effects lack human trial confirmation.

Although A. marmelos has been historically revered in Ayurvedic and Siddha systems for its wide therapeutic applications, its integration into modern clinical practice remains limited by insufficient translational data.

References

• Phytochemical and pharmacological profile of Aegle marmelos (L.) Correa: A comprehensive review of therapeutic potential, mechanisms of action, and translational relevance — Journal of Applied Pharmaceutical Science (2026)
• Sahoo et al. (2025): Exploring the phytochemical constituents of Aegle marmelos (bael) and their therapeutic potential against chronic diseases — International Journal of Basic & Clinical Pharmacology
• Aegle Marmelos — ScienceDirect Topics Overview
• Phytochemical and biological review of Aegle marmelos Linn — PMC (2023)
• Bioactive compounds of Aegle marmelos L., medicinal values and its food applications: A critical review — PubMed (2021)
• Biological activities of crude extracts and chemical constituents of Bael, Aegle marmelos (L.) Corr — PubMed (2010)
• Aegle marmelos (L.): An underutilized plant with incredible pharmaceutical and nutritional potential — ScienceDirect (2025)
• Phytochemistry and medicinal uses of the bael fruit (Aegle marmelos Correa): A concise review — ScienceDirect (2011)
• Marmesin and Marmelosin Interact with the Heparan Sulfatase-2 Active Site: Potential Mechanism for Phytochemicals from Bael Fruit Extract as Antitumor Therapeutics — PMC (2023)
• Ethnopharmacological Profile, Phytochemistry and Therapeutic Potential of Aegle marmelos L. for the Treatment of Neurological Disorders — PMC (2025)
• Phytochemical Analysis and Evaluation of Antioxidant, Antidiabetic, and Anti-inflammatory Properties of Aegle marmelos and Its Validation in an In-Vitro Cell Model — PMC (2024)
• Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit: Validating its traditional usage — BMC Complementary and Alternative Medicine / PMC (2009)
• Aegle marmelos (L.) Correa: An Underutilized Fruit with High Nutraceutical Values: A Review — PMC (2022)
• Comprehensive chemo-profiling of coumarins enriched extract derived from Aegle marmelos (L.) Correa fruit pulp, as an anti-diabetic and anti-inflammatory agent — PMC (2023)
• Phytochemical Study of Aegle marmelos: Chromatographic Elucidation of Polyphenolics and Assessment of Antioxidant and Cytotoxic Potential — PMC (2018)
• Augmentation of hepatoprotective potential of Aegle marmelos in combination with piperine in carbon tetrachloride model in Wistar rats — PMC (2018)
• Efficiency of the leaves and fruits of Aegle marmelos methanol extract and their relative hepatotoxicity — PMC (2019)
• Aegeline: Why is it a problem? — Office of Dietary Supplement Programs/OPSS (U.S. DoD)
• Hepatotoxicity of Herbal and Dietary Supplements: Bodybuilding and Weight Loss Supplements — MDPI (2025)
• OxyELITE Pro — LiverTox® — NCBI Bookshelf, NIH
• Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents — Xenobiotica (2016)
• Antifertility activity of methanolic bark extract of Aegle marmelos (L.) in male Wistar rats — PMC / DARU Journal of Pharmaceutical Sciences (2012)
• Aegle marmelos (Bael): Nutritional, functional and nutraceutical significance — ScienceDirect (2025)
• Phytochemical composition, antilipidemic and antihypercholesterolaemic perspectives of Bael leaf extracts — PMC (2018)
• Characterization of Phytoconstituents, Total Flavonoids and Anti-Oxidant Activity of Aegle marmelos Correa — Current Research in Nutrition and Food Science Journal
• Dietary Supplements Containing Aegeline and DMAA and their Role in Liver Injury — International Journal of Medical Research & Health Sciences
• Bael (Aegle marmelos) fruit-based effervescent tablet formulations: Impact on physicochemical properties, bioactive compounds, and sensory attributes — PMC (2024)